#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Glycogen storage disease type V Erythema Immunodeficiency common variable Chronic lymphocytic leukaemia recurrent High-grade B-cell lymphoma Malignant central nervous system neoplasm Marginal zone lymphoma Hypertriglyceridaemia Head and neck cancer Transient ischaemic attack B-cell lymphoma recurrent Osteogenesis imperfecta Leukocyte adhesion deficiency type I Metabolic disorder More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Diagnostics Tuberous sclerosis complex – Basic Information Mastocytosis – Treatment Mantle cell lymphoma stage II – Treatment Immunodeficiency congenital – Trials in Disease Leiomyosarcoma – Treatment Erdheim-Chester disease – Diagnostics Factor IX deficiency – Diagnostics Sjogren’s syndrome – Diagnostics Pemphigus – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Pantothenate Bp Pegipanermin Haloperidol Bempikibart Autogene Cevumeran 64Cu-Dota-Ae105 Flecainide Acetate Davutamig Cisatracurium Besilate Bepranemab Hydroxypropyl Cellulose Lf Troriluzole Vinorelbine Tartrate Rupatadine Camonsertib Lucerastat EGANELISIB Mk-1167 [Al[18F]F]Fapi-74 Holcus Lanatus Pollen Extract More therapies…

    Learn about Your Condition

    Endometrial cancer Breast cancer stage III Polyneuropathy Meniscus injury Colorectal cancer stage IV Hypotension Subdural haematoma Fallopian tube cancer stage IV Lumbosacral radiculopathy Indolent systemic mastocytosis Yellow fever Eclampsia Otitis media Takayasu's arteritis Polymyositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France

  • Study on Riluzole for Reducing Spasticity in Patients with Chronic Spinal Cord Injury

    Recruiting

    3 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Cellulose, Microcrystalline
    • Riluzole
    France

  • Study on Allopurinol Sodium for Brain Injury Prevention in Newborns with Critical Congenital Heart Disease Undergoing Heart Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Brain injury
    • Heart disease congenital
    Investigated Drugs:
    • Allopurinol Sodium
    The Netherlands

  • Study on Using Furosemide and Hydrochlorothiazide for Treating Patients with Acute Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Investigated Drugs:
    • Furosemide
    • Hydrochlorothiazide
    Spain

  • A Study of Depemokimab and Prednisolone in Adults with Hypereosinophilic Syndrome (HES)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypereosinophilic syndrome
    Investigated Drugs:
    • Depemokimab
    • Prednisolone
    Belgium Czechia Denmark Germany Greece Italy +3

  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    • Myeloproliferative neoplasm
    • Primary myelofibrosis
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Apixaban
    • Rivaroxaban
    France
Previous Page
1 … 328 329 330 331 332 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!